The Centre has decided to increase production of anti-viral drug Remdesivir and it will be provided to people at government's price, said Union Minister Nitin Gadkari on Thursday.
This comes after several cases of black-marketing of Remdesivir came to light amid the COVID-19 pandemic.
"There was a shortage of Remdesivir injection. Because of this, incidents of black marketing took place. several people lost their lives as they have not received Remdesivir. So, we decided to increase its production," mR Gadkari said.
"But we tried (and got manufacturing rights), Remdesivir will be provided to people at government's price. Now, I think there will be no black-marketing and no person will die due to lack of it. There is no reservation. It can be provided to other states when there is surplus," he added.
Mr Gadkari on Thursday visited the Genetic Life Sciences (pharmacy) in Wardha to oversee the production of Remdesivir injections.
There are currently 35,66,398 active cases in the country, as per Union Health Ministry.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
US Lawmakers Back Covid Chinese Lab Leak Theory After Two-Year Probe New XEC Covid Variant Spreads To 27 Countries, Here's What We Know So Far Study Shows How Long Covid Is Debilitating Children's Health Trump Says US Ownership Of Greenland Absolutely Necessary, Nation Responds Delta Airline Passenger Gets Frustrated After His First-Class Seat Was Given To Service Dog Allu Arjun Summoned By Hyderabad Police For Questioning In Stampede Case Former US President Bill Clinton Hospitalised With Fever 21-Year-Old Killed, Another Injured In Stabbing By Juveniles In Delhi: Cops US, UK, EU Condemn Pak Military Courts Over Sentencing Of Civilians Track Latest News Live on NDTV.com and get news updates from India and around the world.